Maximum Daily Dose of Glutathione
For intravenous glutathione, the maximum dose studied in clinical trials is 2.5 g (2500 mg) administered as a single infusion before chemotherapy, though most studies used 1.5 g/m² body surface area. 1 For oral glutathione, doses up to 1000 mg/day have been studied for safety and efficacy in healthy adults, with no serious adverse events reported. 2
Intravenous Administration
The evidence-based dosing range for IV glutathione is 1.5-2.5 g per administration:
- 1.5 g/m² body surface area (approximately 2.5-4 g for average adults) was used in multiple chemotherapy neuropathy prevention trials, administered over 15 minutes immediately before platinum-based chemotherapy 1
- 2.5 g total dose over 15 minutes was the highest single dose studied in the Bogliun 1996 trial for cisplatin-induced neuropathy 1
- These doses were given with each chemotherapy cycle (typically every 2-3 weeks), not daily 1
Critical safety consideration: The American Society of Clinical Oncology found that glutathione is ineffective for taxane-induced neuropathy (paclitaxel/carboplatin) in a 185-patient trial, though it showed benefit for cisplatin and oxaliplatin-induced neuropathy in smaller studies 3
Oral Administration
The maximum studied oral dose is 1000 mg/day:
- 1000 mg/day was the highest dose in a 6-month randomized controlled trial of 54 healthy adults, which increased glutathione levels by 30-35% in blood compartments with no serious adverse events 2
- 500 mg/day showed clinical skin-brightening effects in dermatological studies 4
- 250 mg/day was effective at increasing blood glutathione levels by 17-29% after 6 months 2
Important limitation: Oral glutathione has negligible systemic bioavailability due to hydrolysis by intestinal and hepatic gamma-glutamyltransferase—a single 3 g oral dose did not increase plasma glutathione levels in healthy volunteers 5. However, chronic daily supplementation (250-1000 mg/day) does increase body stores over time 2
S-Acetyl Glutathione (Modified Form)
For S-Acetyl Glutathione, the no-observed-adverse-effect level (NOAEL) is 1500 mg/kg/day in animal studies, which translates to approximately 105,000 mg/day for a 70 kg human using standard safety factors, though human studies have not tested doses this high 6. S-Acetyl Glutathione can be taken with meals for convenience 7
Alternative: N-Acetylcysteine (Glutathione Precursor)
If the goal is to increase glutathione levels systemically, N-acetylcysteine (NAC) 20-50 mg/kg/day is recommended as a more bioavailable precursor 3. For a 70 kg adult, this equals 1400-3500 mg/day of NAC, which cells convert to glutathione 3
Dosing Algorithm
For therapeutic glutathione supplementation:
- If parenteral route is required: Use 1.5 g/m² IV over 15 minutes (maximum 2.5 g per dose), administered intermittently (not daily) 1
- If oral supplementation is preferred: Start with 500 mg/day, may increase to 1000 mg/day for enhanced effect 2
- If bioavailability is a concern: Consider NAC 1400-3500 mg/day instead of glutathione 3
- If using S-Acetyl Glutathione: Doses up to 1000 mg/day appear safe based on standard glutathione studies, though specific long-term human data is limited 6
Critical Pitfalls to Avoid
- Do not confuse glutathione with glutamine—they are different compounds with different indications and dosing 3
- Do not use IV glutathione for taxane-based chemotherapy neuropathy prevention—it is ineffective 3
- Do not expect immediate systemic effects from single oral doses—chronic daily supplementation over months is required to increase body stores 5, 2
- Avoid IV glutathione in patients with contraindications to rapid infusions—anaphylaxis and hepatotoxicity have been reported with IV use 8